Wednesday, February 8, 2023 - 4:00pm

Abstract:

This presentation will highlight at least two examples of drug discovery programs leveraging synthetic organic chemistry combined with innovative and thoughtful molecular design to create and evaluate new potential medicines for the benefit of patients and their communities. 

Speaker: 

Mike Ellis

Institution: 

Bristol Myers Squibb

Location: 

RH 104